title: Use of the hypertensive agent angiotensin II for modifying oxygen delivery to tumours.
authors.affiliation: CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex.
authors.forename: G M
authors.initials: GM
authors.lastname: Tozer
authors.forename: K M
authors.initials: KM
authors.lastname: Shaffi
authors.forename: D G
authors.initials: DG
authors.lastname: Hirst
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D008297:Male; D010100:Oxygen / Q000378:metabolism*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012513:Sarcoma, Experimental / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D000804:Angiotensin II; D010100:Oxygen